Home  >  Products  >  DGCR6L (DiGeorge syndrome critical region gene 6-like) Blocking Peptide (the C terminal of DGCR6L)(100ug)
DGCR6L (DiGeorge syndrome critical region gene 6-like) Blocking Peptide (the C terminal of DGCR6L)(100ug)

DGCR6L (DiGeorge syndrome critical region gene 6-like) Blocking Peptide (the C terminal of DGCR6L)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DGCR6L Antibody (ARP60877_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60877
Size: 100ug
Weight: 25kDa
Gene: 85359
Format: Lyophilized powder
Target: This gene, the result of a duplication at this locus, is one of two functional genes encoding nearly identical proteins that have similar expression patterns. The product of this gene is a protein that shares homology with the Drosophila gonadal protein, expressed in gonadal tissues and germ cells, and with the human laminin gamma-1 chain that functions in cell attachment and migration. This gene is located in a region of chromosome 22 implicated in the DiGeorge syndrome, one facet of a broader collection of anomalies referred to as the CATCH 22 syndrome.
Alternative names: FLJ10666
See Full Product Listings >